Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | TYK2 | P29597 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.51 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.51 |
| ▸ | DHODH | Q02127 | 1/20 | 0.50 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.50 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3140037 | 0.87 | HPGD (0.64) | HPGDSMN1; SMN2TYK2ALDH1A1POLB | |
| SCHEMBL6651792 | 0.85 | HPGD (0.53) | HPGDSMN1; SMN2TYK2ALDH1A1POLB | |
| SCHEMBL3397939 | 0.85 | NPC1 (0.60) | HPGDSMN1; SMN2ALDH1A1POLBNPC1 | |
| SCHEMBL30320291 | 0.85 | HPGD (0.53) | HPGDSMN1; SMN2TYK2ALDH1A1POLB | |
| SCHEMBL27928537 | 0.85 | NPC1 (0.48) | HPGDSMN1; SMN2ALDH1A1POLBNPC1 | |
| SCHEMBL29231950 | 0.83 | HPGD (0.66) | HPGDSMN1; SMN2TYK2ALDH1A1POLB | |
| SCHEMBL29191662 | 0.82 | SMN1; SMN2 (0.62) | HPGDSMN1; SMN2TYK2ALDH1A1POLB | |
| SCHEMBL11589554 | 0.82 | ALDH1A1 (0.42) | HPGDSMN1; SMN2ALDH1A1POLBNPC1 | |
| O-Xylene SCHEMBL28216592 | 0.81 | POLB (0.62) | HPGDSMN1; SMN2ALDH1A1POLBNPC1 | |
| SCHEMBL1068505 | 0.80 | HPGD (0.49) | HPGDSMN1; SMN2TYK2ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080280988-A1 | Use of (N'-Methyl) benzoylurea compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-11-13 | — | — | US | claimed |
| US-20080274884-A1 | Novel use of (N'-methyl)benzoylurea compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-11-06 | — | — | US | claimed |
| US-20080280988-A1 | Use of (N'-Methyl) benzoylurea compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-11-13 | — | — | US | disclosed |
| US-20080280988-A1 | Use of (N'-Methyl) benzoylurea compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-11-13 | — | — | US | disclosed |
| JP-2008266188-A | USE OF (N'-METHYL)BENZOYL UREA COMPOUND | SUMITOMO CHEMICAL CO LTD | 2008-11-06 | — | — | JP | disclosed |
| JP-2008266187-A | USE OF (N'-METHYL)BENZOYL UREA COMPOUND | SUMITOMO CHEMICAL CO LTD | 2008-11-06 | — | — | JP | disclosed |
| US-20080274884-A1 | Novel use of (N'-methyl)benzoylurea compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-11-06 | — | — | US | disclosed |
| US-20080274884-A1 | Novel use of (N'-methyl)benzoylurea compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-11-06 | — | — | US | disclosed |
| US-20080274884-A1 | Novel use of (N'-methyl)benzoylurea compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-11-06 | — | — | US | disclosed |
| JP-2007297375-A | METHOD FOR PROTECTING PLANT | SUMITOMO CHEMICAL CO LTD | 2007-11-15 | — | — | JP | disclosed |
| WO-2007116949-A1 | PLANT PROTECTION METHOD | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007116948-A1 | PLANT PROTECTION METHOD | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-18 | — | — | WO | disclosed |
| CN-85109721-A | Preparation has the ectoparasite of the no disease homoiothermic animal of control and the method for endoparasite compositions | — | 1987-07-15 | — | — | CN | disclosed |
| CN-86100630-A | Preparation contains the method for the sterilant of acylurea | — | 1986-09-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080274884-A1 | Novel use of (N'-methyl)benzoylurea compound | RNGTT, L3MBTL4, MYB | HPGD 4744/4885SMN1; SMN2 820/4885TYK2 3463/4885 |
| US-20080280988-A1 | Use of (N'-Methyl) benzoylurea compound | L3MBTL4, L3MBTL3, L3MBTL1 | HPGD 4558/4885SMN1; SMN2 2295/4885TYK2 4401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.